67 related articles for article (PubMed ID: 26416044)
21. Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic Resection.
Su CW; Chau GY; Hung HH; Yeh YC; Lei HJ; Hsia CY; Lai CR; Lin HC; Wu JC
Ann Surg Oncol; 2015 Jul; 22(7):2253-61. PubMed ID: 25490872
[TBL] [Abstract][Full Text] [Related]
22. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
Güth U; Magaton I; Huang DJ; Fisher R; Schötzau A; Vetter M
Breast; 2014 Feb; 23(1):26-32. PubMed ID: 24215983
[TBL] [Abstract][Full Text] [Related]
23. Resection of liver metastases in patients with breast cancer: survival and prognostic factors.
van Walsum GA; de Ridder JA; Verhoef C; Bosscha K; van Gulik TM; Hesselink EJ; Ruers TJ; van den Tol MP; Nagtegaal ID; Brouwers M; van Hillegersberg R; Porte RJ; Rijken AM; Strobbe LJ; de Wilt JH;
Eur J Surg Oncol; 2012 Oct; 38(10):910-7. PubMed ID: 22682709
[TBL] [Abstract][Full Text] [Related]
24. Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin.
Martin RC; Robbins K; Fagés JF; Romero FD; Rustein L; Tomalty D; Monaco R
Breast Cancer Res Treat; 2012 Apr; 132(2):753-63. PubMed ID: 22200868
[TBL] [Abstract][Full Text] [Related]
25. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B
Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Outcomes Of Surgical Resection for Liver Metastasis from Breast Cancer.
Ye T; Yang B; Tong H; Zhang Y; Xia J
Hepatogastroenterology; 2015 May; 62(139):688-92. PubMed ID: 26897955
[TBL] [Abstract][Full Text] [Related]
27. Liver resection for metastatic non-colorectal non-neuroendocrine hepatic neoplasms.
Karavias DD; Tepetes K; Karatzas T; Felekouras E; Androulakis J
Eur J Surg Oncol; 2002 Mar; 28(2):135-9. PubMed ID: 11884048
[TBL] [Abstract][Full Text] [Related]
28. Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.
Reddy SK; Barbas AS; Marroquin CE; Morse MA; Kuo PC; Clary BM
J Am Coll Surg; 2007 Mar; 204(3):372-82. PubMed ID: 17324770
[TBL] [Abstract][Full Text] [Related]
29. [Hepatic resection for breast cancer metastasis. The concept of adjuvant surgery].
Pocard M; Salmon RJ
Bull Cancer; 1997 Jan; 84(1):47-50. PubMed ID: 9180859
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for patients with liver metastases from breast cancer.
Eichbaum MH; Kaltwasser M; Bruckner T; de Rossi TM; Schneeweiss A; Sohn C
Breast Cancer Res Treat; 2006 Mar; 96(1):53-62. PubMed ID: 16319993
[TBL] [Abstract][Full Text] [Related]
31. Hepatectomy for metastases from breast cancer offers the survival benefit similar to that in hepatic metastases from colorectal cancer.
Kondo S; Katoh H; Omi M; Hirano S; Ambo Y; Tanaka E; Kaji M; Ohtake S; Itoh K; Yamada H; Okushiba S; Morikawa T
Hepatogastroenterology; 2000; 47(36):1501-3. PubMed ID: 11148987
[TBL] [Abstract][Full Text] [Related]
32. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
[TBL] [Abstract][Full Text] [Related]
33. MRI evaluation of small hepatic lesions in women with breast cancer.
Patterson SA; Khalil HI; Panicek DM
AJR Am J Roentgenol; 2006 Aug; 187(2):307-12. PubMed ID: 16861531
[TBL] [Abstract][Full Text] [Related]
34. Survival outcomes and prognostic factors of transcatheter arterial chemoembolization for hepatic neuroendocrine metastases.
Hur S; Chung JW; Kim HC; Oh DY; Lee SH; Bang YJ; Kim WH
J Vasc Interv Radiol; 2013 Jul; 24(7):947-56; quiz 957. PubMed ID: 23602421
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy - a phase II-study.
Wieners G; Mohnike K; Peters N; Bischoff J; Kleine-Tebbe A; Seidensticker R; Seidensticker M; Gademann G; Wust P; Pech M; Ricke J
Radiother Oncol; 2011 Aug; 100(2):314-9. PubMed ID: 21497930
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
37. Liver metastasis rare in colorectal cancer patients with fatty liver.
Hayashi S; Masuda H; Shigematsu M
Hepatogastroenterology; 1997; 44(16):1069-75. PubMed ID: 9261601
[TBL] [Abstract][Full Text] [Related]
38. Intra-hepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancer.
Maes T; Wildiers H; Heye S; Demey W; Maleux G; Neven P; Van Oosterom AT; Paridaens R
Breast Cancer Res Treat; 2008 Jul; 110(1):135-42. PubMed ID: 17851764
[TBL] [Abstract][Full Text] [Related]
39. [Multifocal hepatic steatosis simulating hepatic metastasis].
Urrutia A; Martí S; Inaraja L; Foz M
Med Clin (Barc); 1991 May; 96(20):789-90. PubMed ID: 1875768
[No Abstract] [Full Text] [Related]
40. Relationship between hepatic and pancreatic steatosis and the COVID-19 pneumonia total severity score and prognosis with an emphasis on prognostic strength.
Doğan H; Uzer E; Esengür ÖT; Hassoy H; Güneyli S
Diagn Interv Radiol; 2023 Jul; 29(4):363-370. PubMed ID: 36960637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
